Literature DB >> 2757017

Acinetobacter peritonitis during chronic peritoneal dialysis.

C Galvao1, R Swartz, L Rocher, J Reynolds, B Starmann, D Wilson.   

Abstract

Among gram-negative bacilli isolated during peritonitis in chronic peritoneal dialysis (CPD), Pseudomonas species are most common but Acinetobacter species are nearly as frequent. A survey of more than 450 patient-years' experience with CPD revealed 23 episodes of Acinetobacter peritonitis (AP), making this the second most common form of gram-negative peritonitis. Concomitant break in sterile technique and exit-site/tunnel infection were infrequent. AP appeared as the first peritonitis episode in five cases and as the second in six cases, and the duration of CPD at the time of AP ranged from less than 1 to greater than 56 months. However, AP was noted to appear shortly after treatment of another peritonitis episode or shortly after CPD access placement, within 2 months in 11 cases (47%) and within 3 months in 14 cases (61%). Treatment with intraperitoneal antibiotics succeeded in 21 cases (91%) without CPD interruption or catheter removal, with tobramycin or gentamicin alone in 16 cases, and with combined aminoglycoside and penicillin or cephalosporin in six cases. In two cases intraperitoneal antibiotics alone were insufficient therapy: one case with concomitant tunnel infection and dialysate leak and one case with bacteremia while receiving corticosteroids. The time-dependent incidence of AP suggests opportunistic infection during a vulnerable period in the first 2 to 3 months following another peritonitis episode, but AP also appears amenable to intraperitoneal antibiotic therapy alone without interruption of the CPD routine in the majority of cases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2757017     DOI: 10.1016/s0272-6386(89)80184-2

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

Review 1.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

Review 2.  Peritoneal dialysis-related peritonitis with Acinetobacter baumannii: a review of seven cases.

Authors:  Wei Zhang; Yong-Gui Wu; Xiang-Ming Qi; Hong Dai; Wen Lu; Min Zhao
Journal:  Perit Dial Int       Date:  2013-12-01       Impact factor: 1.756

Review 3.  Bacteremia due to Acinetobacter species other than Acinetobacter baumannii.

Authors:  H Seifert; A Strate; A Schulze; G Pulverer
Journal:  Infection       Date:  1994 Nov-Dec       Impact factor: 3.553

4.  Acinetobacter peritoneal dialysis peritonitis: a changing landscape over time.

Authors:  Chia-Ter Chao; Szu-Ying Lee; Wei-Shun Yang; Huei-Wen Chen; Cheng-Chung Fang; Chung-Jen Yen; Chih-Kang Chiang; Kuan-Yu Hung; Jenq-Wen Huang
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

5.  Acinetobacter lwoffii Peritonitis in a Patient on Automated Peritoneal Dialysis: A Case Report and Review of the Literature.

Authors:  Murat Yasar Tas; Meral Merve Oguz; Mevlut Ceri
Journal:  Case Rep Nephrol       Date:  2017-07-26

6.  Microbiology and Outcome of Peritoneal Dialysis-Related Peritonitis in Elderly Patients: A Retrospective Study in China.

Authors:  Panai Song; Dong Yang; Jine Li; Ning Zhuo; Xiao Fu; Lei Zhang; Hongqing Zhang; Hong Liu; Lin Sun; Yinghong Liu
Journal:  Front Med (Lausanne)       Date:  2022-04-14

7.  Acute blindness in a dog with Acinetobacter-associated postencephalitic hydrocephalus.

Authors:  Jung-Hyun Kim; Ji-Hee Jeon; Kang-Hyo Park; Hun-Young Yoon; Joon-Young Kim
Journal:  J Vet Med Sci       Date:  2017-08-28       Impact factor: 1.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.